Long-Term Assets: The sum of all assets classified as non-current.
Rocket Pharmaceuticals, Inc. (RCKT) had Long-Term Assets of $140.35M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-50.33M |
|
-- |
|
-- |
|
$52.25M |
|
$-52.25M |
|
$1.92M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-52.25M |
|
$-49.01M |
|
111.57M |
|
111.57M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$227.68M |
|
$29.77M |
|
|
Long-Term Assets |
$140.35M |
$368.03M |
|
$31.17M |
|
$19.38M |
|
$23.19M |
|
$54.36M |
|
$313.67M |
|
$249.37M |
|
$313.67M |
|
108.21M |
|
| Cash Flow Statement Financials | |
$-155.17M |
|
$67.34M |
|
$0.15M |
|
$165.00M |
|
$77.31M |
|
$-87.68M |
|
$30.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.30 |
|
-- |
|
-- |
|
0.06 |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-155.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.05% |
|
-20.18% |
|
-13.68% |
|
-15.11% |
|
$2.90 |
|
$-1.39 |
|
$-1.39 |
|